test-could-help-identify-patients-at-risk-for-severe-scleroderma

A recent investigation from Yale identifies type 1 interferons as a possible indicator for scleroderma individuals with a poorer outlook.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This